Article History
Received: 28 March 2019
Accepted: 11 June 2019
First Online: 21 June 2019
Ethics approval and consent to participate
: N/A, no new patient data presented.
: N/A, no new patient data presented.
: DFS declares to receive consulting fees from Robarts Clinical Trials Inc. and honoraria from Amgen Canada.